Guggenheim Capital’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Guggenheim Capital’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,061	Closed	-$289K	–	1701
2025 Q1	$289K	Hold	16,061	–	–	﹤0.01%	1421
2024 Q4	$281K	Buy	+16,061	New	+$217K	﹤0.01%	1472
2023 Q3	–	Sell	-24,889	Closed	-$188K	–	1927
2023 Q2	$188K	Sell	24,889 -1,597	-6%	-$12.2K	﹤0.01%	1785
2023 Q1	$212K	Buy	26,486 +984	+4%	+$10.1K	﹤0.01%	1785
2022 Q4	$290K	Sell	25,502 -1,439	-5%	-$15.7K	﹤0.01%	1680
2022 Q3	$235K	Buy	26,941 +4,914	+22%	+$51K	﹤0.01%	1739
2022 Q2	$220K	Buy	+22,027	New	+$222K	﹤0.01%	1907

Guggenheim Capital's PTVE Position: Q2 2025 in Review

Guggenheim Capital sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 16,061 shares — an estimated $289K sold.

Guggenheim Capital first reported a position in PTVE in Q2 2022 and held it in 7 quarters. The position peaked at $290K in Q4 2022. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

Guggenheim Capital reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
Guggenheim Capital sold 16,061 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $289K.
Guggenheim Capital first reported a position in Pactiv Evergreen Inc. Common stock in Q2 2022 and held it in 7 quarters.
Guggenheim Capital's Pactiv Evergreen Inc. Common stock position peaked at $290K in Q4 2022.
0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Guggenheim Capital's 13F filing for Q2 2025, filed 13 Aug 2025.